NUIX LIMITED — Director's Dealing 2022

Dec 19, 2022

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity NUIX LIMITED ABN 80 117 140 235

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	JONATHAN RUBINSZTEIN
Date of last notice	08 SEPTEMBER 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Direct and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		The Trustee of Yazarskia Super Fund (of which Mr Rubinsztein is a beneficiary)
Date of change		16 December 2022
No. of securities held prior to change		Indirect 500,000 Fully Paid Ordinary Shares
Class		Performance Rights
Number acquired		2,348,370
Number disposed		-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		NIL

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change		Indirect 500,000 Fully Paid Ordinary Shares Direct 2,348,370 Performance Rights
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Issue of:- (a) 110,230 Performance Rightsapproved by shareholders at the Company’s Annual General Meeting held on 18/11/22 in relation to FY22 STI. Each performance right will vest in the first trading window after 12 months (that is following 18 August 2023) subject to Mr Rubsinsztein remaining employed by the Company at that time. (b) 239,632 Performance Rightsapproved by shareholders at the Company’s Annual General Meeting held on 18/11/22 in relation to FY22 LTI awards granted to the CEO and other Executive KMP during FY22. Each performance right is subject to performance testing, and if targets are met, one third of the vested LTI performance rights will be available upon the release of the Company’s financial results of FY24, FY25 and FY26. Vesting is also subject to Mr Rubsinsztein remaining employed by the Company at those times. (c) 711,744 Performance Rightsapproved by shareholders at the Company’s Annual General Meeting held on 18/11/22 in relation to a Sign-on Grant. The performance rights will vest in five equal tranches in the first trading window following the first and subsequent anniversary date from 06 December 2021. Vesting is subject to Mr Rubsinsztein remaining employed by the Company at those times. (d) 1,286,764 Performance Rightsapproved by shareholders at the Company’s Annual General Meeting held on 18/11/22 in relation to FY23 LTI Plan. Each performance right is subject to performance testing against Annualised Contract Value (ACV) targets as at the end of FY23, and if targets are met, one half of the vested LTI performance rights will be available upon the release of the Company’s financial results for each FY24 and FY25. Vesting is also subject to Mr Rubsinsztein remaining employed by the Company at those times.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract n/a

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Nature of interest	n/a
Name of registered holder (if issued securities)	n/a
Date of change	n/a
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	n/a
Interest acquired	n/a
Interest disposed	n/a
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	n/a
Interest after change	n/a

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3